IBDEI0RD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12837,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,12837,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,12838,0)
 ;;=L21.9^^53^582^263
 ;;^UTILITY(U,$J,358.3,12838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12838,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12838,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,12838,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,12839,0)
 ;;=L23.7^^53^582^30
 ;;^UTILITY(U,$J,358.3,12839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12839,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,12839,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,12839,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,12840,0)
 ;;=L23.9^^53^582^31
 ;;^UTILITY(U,$J,358.3,12840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12840,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12840,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,12840,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,12841,0)
 ;;=L24.9^^53^582^163
 ;;^UTILITY(U,$J,358.3,12841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12841,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12841,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,12841,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,12842,0)
 ;;=L25.9^^53^582^115
 ;;^UTILITY(U,$J,358.3,12842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12842,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,12842,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,12842,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,12843,0)
 ;;=L26.^^53^582^148
 ;;^UTILITY(U,$J,358.3,12843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12843,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,12843,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,12843,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,12844,0)
 ;;=L27.0^^53^582^265
 ;;^UTILITY(U,$J,358.3,12844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12844,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,12844,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,12844,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,12845,0)
 ;;=L27.1^^53^582^266
 ;;^UTILITY(U,$J,358.3,12845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12845,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,12845,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,12845,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,12846,0)
 ;;=L29.0^^53^582^250
 ;;^UTILITY(U,$J,358.3,12846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12846,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,12846,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,12846,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,12847,0)
 ;;=L29.9^^53^582^251
 ;;^UTILITY(U,$J,358.3,12847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12847,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,12847,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,12847,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,12848,0)
 ;;=L30.0^^53^582^232
 ;;^UTILITY(U,$J,358.3,12848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12848,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,12848,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,12848,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,12849,0)
 ;;=L30.1^^53^582^140
 ;;^UTILITY(U,$J,358.3,12849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12849,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,12849,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,12849,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,12850,0)
 ;;=L30.2^^53^582^132
 ;;^UTILITY(U,$J,358.3,12850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12850,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,12850,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,12850,2)
 ;;=^5009155
